Bipin N. Savani

Bipin N. Savani publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Bipin N. Savani sits on this spectrum.

Bipin N. Savani D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Bipin N. Savani sits on this spectrum.

Overview

Best Publications

• First- and second-line systemic treatment of acute graft-versus-host disease: recommendations of the American Society of Blood and Marrow Transplantation.

  Paul J. Martin;J. Douglas Rizzo;John R. Wingard;Karen Ballen

  676
  Citations

• Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation

  M. Mohty;F. Malard;M. Abecassis;E. Aerts

  586
  Citations

• Early cytomegalovirus reactivation remains associated with increased transplant related mortality in the current era: a CIBMTR analysis

  Pierre Teira;Minoo Battiwalla;Muthalagu Ramanathan;A. John Barrett

  488
  Citations

• High donor FOXP3-positive regulatory T-cell (Treg) content is associated with a low risk of GVHD following HLA-matched allogeneic SCT.

  Katayoun Rezvani;Stephan Mielke;Mojgan Ahmadzadeh;Yasemin Kilical

  480
  Citations

• Indications for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines from the American Society for Blood and Marrow Transplantation

  Navneet S. Majhail;Stephanie H. Farnia;Paul A. Carpenter;Richard E. Champlin

  477
  Citations

• Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant Research

  Sally Arai;Mukta Arora;Tao Wang;Tao Wang;Stephen R. Spellman

  475
  Citations

• Leukemia-associated antigen-specific T-cell responses following combined PR1 and WT1 peptide vaccination in patients with myeloid malignancies.

  Katayoun Rezvani;Agnes S.M. Yong;Stephan Mielke;Bipin N. Savani

  445
  Citations

• Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015

  A. Sureda;P. Bader;S. Cesaro;P. Dreger

  435
  Citations

• Sinusoidal obstruction syndrome/veno-occlusive disease: Current situation and perspectives - A position statement from the European Society for Blood and Marrow Transplantation (EBMT)

  M. Mohty;F. Malard;M. Abecassis;E. Aerts

  405
  Citations

• Reduced-Intensity Transplantation for Lymphomas Using Haploidentical Related Donors Versus HLA-Matched Sibling Donors: A Center for International Blood and Marrow Transplant Research Analysis.

  Nilanjan Ghosh;Reem Karmali;Vanderson Rocha;Kwang Woo Ahn

  286
  Citations

• Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States

  Lori Muffly;Marcelo C. Pasquini;Michael Martens;Ruta Brazauskas

  283
  Citations

• The European Society for Blood and Marrow Transplantation (EBMT) Consensus Guidelines for the Detection and Treatment of Donor-specific Anti-HLA Antibodies (DSA) in Haploidentical Hematopoietic Cell Transplantation.

  Stefan O. Ciurea;Kai Cao;Marcelo Fernadez-Vina;Piyanuch Kongtim

  269
  Citations

• Graft-versus-leukemia effects associated with detectable Wilms tumor-1-specific T lymphocytes after allogeneic stem-cell transplantation for acute lymphoblastic leukemia

  Katayoun Rezvani;Agnes S. M. Yong;Bipin N. Savani;Stephan Mielke

  243
  Citations

• Peripheral Blood Progenitor Cell Mobilization for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines from the American Society for Blood and Marrow Transplantation

  Hien K. Duong;Bipin N. Savani;Ed Copelan;Steven Devine

  234
  Citations

• Rapid natural killer cell recovery determines outcome after T-cell-depleted HLA-identical stem cell transplantation in patients with myeloid leukemias but not with acute lymphoblastic leukemia

  B N Savani;S Mielke;S Adams;M Uribe

  233
  Citations

• National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: V. The 2014 Ancillary Therapy and Supportive Care Working Group Report

  Paul A. Carpenter;Carrie L. Kitko;Sharon Elad;Mary E.D. Flowers

  233
  Citations

• Relapse of AML after hematopoietic stem cell transplantation: methods of monitoring and preventive strategies. A review from the ALWP of the EBMT.

  P. Tsirigotis;M. Byrne;C. Schmid;Frédéric Baron

  231
  Citations

• Use of tyrosine kinase inhibitors to prevent relapse after allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: A position statement of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

  Sebastian Giebel;Anna Czyz;Oliver Ottmann;Frederic Baron

  220
  Citations

• Improved Outcomes After Autologous Hematopoietic Cell Transplantation for Light Chain Amyloidosis: A Center for International Blood and Marrow Transplant Research Study

  Anita D'Souza;Angela Dispenzieri;Baldeep Wirk;Mei Jie Zhang

  202
  Citations

• Selective depletion of alloreactive donor lymphocytes: a novel method to reduce the severity of graft-versus-host disease in older patients undergoing matched sibling donor stem cell transplantation.

  Scott R. Solomon;Stephan Mielke;Stephan Mielke;Bipin N. Savani;Bipin N. Savani;Aldemar Montero;Aldemar Montero

  197
  Citations